Protalix BioTherapeutics (PLX) Depreciation & Amortization - Total (2024 - 2026)
Protalix BioTherapeutics' quarterly Depreciation & Amortization - Total came in at $404000.0 in Q1 2026, up 16.76% year-on-year from $346000.0 in Q1 2025, and up 4.39% quarter-over-quarter from $387000.0 in Q4 2025.
Protalix BioTherapeutics has reported Depreciation & Amortization - Total for 3 years, with the latest figure at $404000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization - Total rose 16.76% year-over-year to $404000.0; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (up 14.68% YoY), and the FY2025 full-year result was $1.5 million, up 12.35% from the prior year.
- Depreciation & Amortization - Total for Q1 2026 stood at $404000.0, up from $387000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization - Total was $404000.0 in Q1 2026, with the low at $319000.0 in Q2 2024.
- Average Depreciation & Amortization - Total over 3 years is $356375.0, with a median of $353000.0 recorded in 2025.
- Year-over-year, Depreciation & Amortization - Total rose 12.85% in 2025 and rose 16.76% in 2026.
- Tracing PLX's Depreciation & Amortization - Total over 3 years: stood at $334000.0 in 2024, then climbed by 15.87% to $387000.0 in 2025, then increased by 4.39% to $404000.0 in 2026.
- The last three Depreciation & Amortization - Total figures came in at $404000.0 (Q1 2026), $387000.0 (Q4 2025), and $372000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 404,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 404,000.00 |
| Dec 31, 2025 | 387,000.00 |
| Sep 30, 2025 | 372,000.00 |
| Jun 30, 2025 | 360,000.00 |
| Mar 31, 2025 | 346,000.00 |
| Dec 31, 2024 | 334,000.00 |
| Sep 30, 2024 | 329,000.00 |
| Jun 30, 2024 | 319,000.00 |